<?xml version="1.0"?>
<Articles JournalTitle="Basic &amp; Clinical Cancer Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Basic &amp; Clinical Cancer Research</JournalTitle>
      <Issn>2228-6527</Issn>
      <Volume>17</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>10</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">HER2 Status in Breast Cancer in Relation to Age and Tumor Histological Type: A Cross-Sectional Study from Karbala Iraq</title>
    <FirstPage>54</FirstPage>
    <LastPage>62</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hussein Mahdi</FirstName>
        <LastName>Kadhim</LastName>
        <affiliation locale="en_US">College of Medicine, University of Kerbala, Karbala, Iraq</affiliation>
      </Author>
      <Author>
        <FirstName>BAHAA Aldeen</FirstName>
        <LastName>HADI</LastName>
        <affiliation locale="en_US">University of kerbala</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>08</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>09</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">BACKGROUND HER2 overexpression marks out a biologically aggressive targetable subset of breast cancer accounting for 15&#x2013;20% of cases in Western series Data from Iraq are limited and Karbala Province has not been studied before
&#xD;

MATERIALS AND METHODS We reviewed 99 women with confirmed invasive breast cancer at a single Karbala centre grouped into four age bands (28&#x2013;39 40&#x2013;49 50&#x2013;59 60&#x2013;69 years) HER2 was scored 0 1+ 2+ or 3+ by immunohistochemistry (IHC) using the 2013 ASCOCAP guideline We tested associations with age and histological type using chisquare tests and multivariable logistic regression (HER2 3+ as the dependent variable) reporting odds ratios (OR) and 95% confidence intervals (CI)
&#xD;

RESULTS The 40&#x2013;49year band was largest (333%) Invasive ductal carcinoma was the most common type (566%) followed by locally advanced disease (162%) invasive lobular carcinoma (121%) metastatic carcinoma (81%) and triplenegative breast cancer (71%) Fortyseven tumours (475%) were HER2negative (IHC 0); of the rest 13 (131%) scored 1+ 13 (131%) scored 2+ (equivocal) and 26 (263%) scored 3+ meeting strict ASCOCAP positivity criteria HER2 score was not linked to age (&#x3C7;&#xB2; = 782 p = 025) but histology varied significantly with age (&#x3C7;&#xB2; = 524 p &lt; 0001) No variable independently predicted HER2 3+ positivity (IDC vs other: OR 175 95% CI 068&#x2013;452 p = 024)
&#xD;

CONCLUSIONS Over half of this cohort showed detectable HER2 expression and the strict HER2positivity rate (263%) is higher than the global benchmark in line with other Arab cohorts Reflex FISH was not available onsite to confirm equivocal (2+) cases pointing to a need for expanded confirmatory testing Histology but not age alone varied meaningfully across age groups which should inform diagnostic planning</abstract>
    <web_url>https://bccr.tums.ac.ir/index.php/bccrj/article/view/608</web_url>
  </Article>
</Articles>
